Pharma news
Here are some recent pharma news updates:
1. COVID-19 Vaccine Updates
- Pfizer and BioNTech have announced that their COVID-19 vaccine has been approved for emergency use in the UK, making it the first vaccine to receive approval in the country. (Source: Reuters)
- Moderna Therapeutics has announced that its COVID-19 vaccine has been approved for emergency use in the US, with the first shipments expected to be delivered in the coming days. (Source: Moderna Therapeutics)
2. FDA Approvals
- The FDA has approved AstraZeneca's Brilinta (ticagrelor) to reduce the risk of cardiovascular death, heart attack, and stroke in patients with acute coronary syndromes. (Source: AstraZeneca)
- The FDA has approved Novartis' Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with heart failure with reduced ejection fraction. (Source: Novartis)
3. Clinical Trials
- Johnson & Johnson has announced that its COVID-19 vaccine candidate has shown promising results in a Phase 1 clinical trial, with 90% of participants producing antibodies against the virus. (Source: Johnson & Johnson)
- Eli Lilly and Company has announced that its COVID-19 antibody treatment has shown promising results in a Phase 2 clinical trial, with 80% of participants showing a reduction in viral load. (Source: Eli Lilly and Company)
4. Mergers and Acquisitions
- Pfizer has announced that it will acquire Arena Pharmaceuticals for $6.7 billion, expanding its portfolio of treatments for rare diseases. (Source: Pfizer)
- Sanofi has announced that it will acquire Principia Biopharma for $3.2 billion, gaining access to Principia's pipeline of immunology treatments. (Source: Sanofi)
5. Regulatory News
- The European Medicines Agency (EMA) has announced that it will conduct a review of the safety and efficacy of Johnson & Johnson's COVID-19 vaccine candidate, following reports of rare blood clotting disorders in some recipients. (Source: EMA)
- The FDA has announced that it will conduct a review of the safety and efficacy of Pfizer's COVID-19 vaccine candidate, following reports of rare allergic reactions in some recipients. (Source: FDA)
These are just a few of the latest pharma news updates. If you'd like to stay up-to-date on the latest news and developments in the pharmaceutical industry, I'd be happy to help you with that!